Super-Cross-Reactive Recognition Enables Preclinical Diagnosis of Alzheimer’s Disease
In the authors' words
This journal does not let us republish the full abstract. Here are the two sentences Pipette selected, quoted from it. Read the rest at the publisher.
Main result
This work presents a clinically viable tool for early AD diagnosis and establishes a generalizable, modular framework for multiplexed biomarker analysis in neurodegenerative diseases.
Appeared: Saturday, October 17. Journal of the American Chemical Society. Peer-reviewed journal.
DOI: 10.1021/jacs.6c14717